Showing results (341-350 of 602) with videos related to

Sort By:
Pageof 61
Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.
Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75M Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Cancer|May 5, 2016
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Advances|April 5, 2018
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2018
Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain AmyloidosisM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.
Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Mayo Clinic Proceedings|May 20, 2014
Remission of disseminated cancer after systemic oncolytic virotherapyStephen J Russell, Mark J Federspiel, Kah-Whye Peng, et al.
Frontiers in Immunology|June 25, 2024
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myelomaDoris K Hansen, Binod Dhakal, Mehdi Hamadani, et al.
Pageof 61